Company profile

Vonova company profile

Vonova is developing a breakthrough catheter platform as the first alternative to drilling through the skull for the $2B+ brain interface market—a broad category of interventions addressing chronic neurological disorders with cortical electrodes for both recording and stimulating. The company's flagship product, the Cerebro Atlas System, will provide neuromodulation therapy for drug-resistant chronic pain without the high risk and discomfort associated with invasive brain surgery. Founded in 2022 by a management team with expertise in catheter device development and neurology, Vonova has issued US patents, demonstrated the procedure's feasibility with clinical key opinion leaders, and received an NIH Blueprint Seed..... For more information, log in to dureach.com to view the full company profile.

Business identity

Operating status
Active
Company type
For Profit
Employee range
00001-00010 employees
Founded
2021-01-01

Headquarters

Headquarters
Wonewoc, Wisconsin, United States
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
2
Last funding
Pre Seed / 2024-08-20
Last equity funding
Pre Seed
Investors
2
Lead investors
2
Founders
2
Articles
3

Founders and investors

Founders

Jose MoralesWesley Jones

Lead investors

MedTech InnovatorSmartGateVC

Investors

MedTech InnovatorSmartGateVC

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.